Charles D. Spencer

558 citations
7 papers · 296 indexed · h-index 7
Topics
Cancer therapeutics and mechanisms (4 papers)Cancer-related Molecular Pathways (4 papers)Catalytic C–H Functionalization Methods (3 papers)
Partner nations
United StatesSpain

In The Last Decade

Charles D. Spencer

7 papers receiving 285 citations

Peers

Charles D. Spencer
Comparison fields: 5 of 47
  • Organic Chemistry 174
  • Molecular Biology 116
  • Oncology 70
  • Pulmonary and Respiratory Medicine 38
  • Toxicology 37
Replace Ching-Ping Chen with:
Ching-Ping Chen Taiwan
Cai-hua Zhu China
Amalia Cipollone Italy
Meining Wang China
Kin‐Chun Luk United States
Zizhao Guo China
David R. Goode United States
Jean‐Michel Robert France
Supriya Bhukya India
François Soucy Canada
Charles D. Spencer relative to Ching-Ping Chen Taiwan Ching-Ping Chen's profile →
Citations per field
00.5×1.7×
Ching-Ping Chen · 1×
Citations per year

Countries citing papers authored by Charles D. Spencer

Since Specialization
Citations

This map shows the geographic impact of Charles D. Spencer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles D. Spencer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles D. Spencer more than expected).

Fields of papers citing papers by Charles D. Spencer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles D. Spencer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles D. Spencer. The network helps show where Charles D. Spencer may publish in the future.

Co-authorship network of co-authors of Charles D. Spencer

This figure shows the co-authorship network connecting the top 25 collaborators of Charles D. Spencer. A scholar is included among the top collaborators of Charles D. Spencer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles D. Spencer. Charles D. Spencer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 78
2 36
3 18
4 23
5 28
6 29
7 84

About Charles D. Spencer

Charles D. Spencer is a scholar working on Toxicology, Pathology and Forensic Medicine and Oncology, having authored 7 papers that have together received 296 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), Cancer-related Molecular Pathways (4 papers) and Catalytic C–H Functionalization Methods (3 papers). The work is most often cited by research in Toxicology (37 citations), Organic Chemistry (174 citations) and Oncology (70 citations). Charles D. Spencer has collaborated with scholars based in United States and Spain. Frequent co-authors include Harold B. Brooks, Scott A. Watkins, Eileen L. Considine, Chuan Shih, Richard M. Schultz, Jack Dempsey, Guoxin Zhu, Bryan D. Anderson, Faming Zhang and Scott E. Conner. Their work appears in journals such as Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026